Page last updated: 2024-10-31

metoclopramide and Carcinoma, Pancreatic Ductal

metoclopramide has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tandon, M1
Coudriet, GM1
Criscimanna, A1
Socorro, M1
Eliliwi, M1
Singhi, AD1
Cruz-Monserrate, Z1
Bailey, P1
Lotze, MT1
Zeh, H1
Hu, J1
Goffin, V1
Gittes, GK1
Biankin, AV1
Esni, F1

Other Studies

1 other study available for metoclopramide and Carcinoma, Pancreatic Ductal

ArticleYear
Prolactin Promotes Fibrosis and Pancreatic Cancer Progression.
    Cancer research, 2019, 10-15, Volume: 79, Issue:20

    Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Collagen; Disease Progression; Epithelium;

2019